Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global $15.4 Billion Ortho Biological Products Market Report Insights, Opportunity Analysis, Market Shares and Forecasts 2016 - 2022 - Research and Markets

Research and Markets
Posted on: 28 Nov 16

Research and Markets has announced the addition of the "Global Ortho Biological Products Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022" report to their offering.

The global ortho biological products market is anticipated to grow to $15.4 billion during 2016- 2022

Due to Rising of ortho biological products is driven by growing awareness towards adoption of orthobiologics, development in technology, and increasing number of orthopedic related process. Further specific restraint such as high cost associated with the products. These products have high costs, that are beyond the affordability of few people and it is restricting the growth of the market.

The segments of the ortho biological products market are on the basis of the applications, products, and region. The products market segmentation is on the basis of Demineralized Bone Matrix, machined bones, allograft, Bone Morphogenetic Protein, machined bones, visco supplementation, stem cell therapy, and other applications.

Orthopedic surgery was restricted to metal and screw implants to repair the damages and fractured bones, wherever, development in technology has propelled the field of orthopedics with the latest alternatives that are providing better comfort and durability.

Orthobiologics includes use of biology and biochemistry in development of bone and tissue replacement materials. This is the rapidly growing segment of the orthopedic industry as it has offered alternatives for traditional bone and tissue repair provide better durability. Orthobiologics is helping in rising the strength and ability of repair and minimize the length of the postoperative period.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Competitive Landscape

5. Global Orthobiological Products Market By Region (Revenue Analysis), 2014-2022 ($ Million)

6. Company Profiles

- Allograft Tissue Systems

- Baxter International Inc.

- Berkeley Advanced Biomaterials Inc.

- Bioventus

- Bone Biologics Inc.

- Bone Solutions Inc.

- DePuySynthes Inc.

- Globus Medical

- Integra Life Sciences Corp.

- International

- Medtronic Inc.

- Pioneer Surgical Technology

- Sanofi

- Smith and Nephew Plc

- Stryker Corp

- Tissue Banks Osiris Therapeutics Inc.

- Tissue Genesis Inc.

For more information about this report visit http://www.researchandmarkets.com/research/cbq4p9/global_ortho

View source version on businesswire.com: http://www.businesswire.com/news/home/20161128005942/en/

Business Wire
www.businesswire.com

Last updated on: 28/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.